BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Ozempic Knock Offs Contain Unsafe Substance Banned by FDA, Novo Finds Bloomberg FDA's Overreach on Compounded Peptides FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News